United States Anticoagulants Drug Market Report 2017

December 2017 | 109 pages | ID: UF71BB57839EN
QYResearch

Abstracts

In this report, the United States Anticoagulants Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Anticoagulants Drug in these regions, from 2012 to 2022 (forecast).

United States Anticoagulants Drug market competition by top manufacturers/players, with Anticoagulants Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• C. H. Boehringer Sohn (Germany)
• Bristol-Myers Squibb (US)
• Johnson & Johnson (US)
• Pfizer (US)
• Daiichi Sankyo (Japan)
• Portola Pharmaceuticals (US)
• Roche (Switzerland)
• Abbott (US)
• Siemens (Germany)
• Alere (US)
• CoaguSense (US)

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Novel Oral Anticoagulants (NOACs)
• Warfarin (VKA)
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Clinic
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Anticoagulants Drug Market Report 2017

1 ANTICOAGULANTS DRUG OVERVIEW

1.1 Product Overview and Scope of Anticoagulants Drug
1.2 Classification of Anticoagulants Drug by Product Category
  1.2.1 United States Anticoagulants Drug Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Anticoagulants Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Novel Oral Anticoagulants (NOACs)
  1.2.4 Warfarin (VKA)
  1.2.5 Others
1.3 United States Anticoagulants Drug Market by Application/End Users
  1.3.1 United States Anticoagulants Drug Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Others
1.4 United States Anticoagulants Drug Market by Region
  1.4.1 United States Anticoagulants Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Anticoagulants Drug Status and Prospect (2012-2022)
  1.4.3 Southwest Anticoagulants Drug Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Anticoagulants Drug Status and Prospect (2012-2022)
  1.4.5 New England Anticoagulants Drug Status and Prospect (2012-2022)
  1.4.6 The South Anticoagulants Drug Status and Prospect (2012-2022)
  1.4.7 The Midwest Anticoagulants Drug Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Anticoagulants Drug (2012-2022)
  1.5.1 United States Anticoagulants Drug Sales and Growth Rate (2012-2022)
  1.5.2 United States Anticoagulants Drug Revenue and Growth Rate (2012-2022)

2 UNITED STATES ANTICOAGULANTS DRUG MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Anticoagulants Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Anticoagulants Drug Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Anticoagulants Drug Average Price by Players/Suppliers (2012-2017)
2.4 United States Anticoagulants Drug Market Competitive Situation and Trends
  2.4.1 United States Anticoagulants Drug Market Concentration Rate
  2.4.2 United States Anticoagulants Drug Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Anticoagulants Drug Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ANTICOAGULANTS DRUG SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Anticoagulants Drug Sales and Market Share by Region (2012-2017)
3.2 United States Anticoagulants Drug Revenue and Market Share by Region (2012-2017)
3.3 United States Anticoagulants Drug Price by Region (2012-2017)

4 UNITED STATES ANTICOAGULANTS DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Anticoagulants Drug Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Anticoagulants Drug Revenue and Market Share by Type (2012-2017)
4.3 United States Anticoagulants Drug Price by Type (2012-2017)
4.4 United States Anticoagulants Drug Sales Growth Rate by Type (2012-2017)

5 UNITED STATES ANTICOAGULANTS DRUG SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Anticoagulants Drug Sales and Market Share by Application (2012-2017)
5.2 United States Anticoagulants Drug Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES ANTICOAGULANTS DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 C. H. Boehringer Sohn (Germany)
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Anticoagulants Drug Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 C. H. Boehringer Sohn (Germany) Anticoagulants Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Bristol-Myers Squibb (US)
  6.2.2 Anticoagulants Drug Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bristol-Myers Squibb (US) Anticoagulants Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Johnson & Johnson (US)
  6.3.2 Anticoagulants Drug Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Johnson & Johnson (US) Anticoagulants Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Pfizer (US)
  6.4.2 Anticoagulants Drug Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Pfizer (US) Anticoagulants Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Daiichi Sankyo (Japan)
  6.5.2 Anticoagulants Drug Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Daiichi Sankyo (Japan) Anticoagulants Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Portola Pharmaceuticals (US)
  6.6.2 Anticoagulants Drug Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Portola Pharmaceuticals (US) Anticoagulants Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Roche (Switzerland)
  6.7.2 Anticoagulants Drug Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Roche (Switzerland) Anticoagulants Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Abbott (US)
  6.8.2 Anticoagulants Drug Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Abbott (US) Anticoagulants Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Siemens (Germany)
  6.9.2 Anticoagulants Drug Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Siemens (Germany) Anticoagulants Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Alere (US)
  6.10.2 Anticoagulants Drug Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Alere (US) Anticoagulants Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 CoaguSense (US)

7 ANTICOAGULANTS DRUG MANUFACTURING COST ANALYSIS

7.1 Anticoagulants Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Anticoagulants Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Anticoagulants Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Anticoagulants Drug Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ANTICOAGULANTS DRUG MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Anticoagulants Drug Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Anticoagulants Drug Sales Volume Forecast by Type (2017-2022)
11.3 United States Anticoagulants Drug Sales Volume Forecast by Application (2017-2022)
11.4 United States Anticoagulants Drug Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Anticoagulants Drug
Figure United States Anticoagulants Drug Market Size (K Pcs) by Type (2012-2022)
Figure United States Anticoagulants Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Novel Oral Anticoagulants (NOACs) Product Picture
Figure Warfarin (VKA) Product Picture
Figure Others Product Picture
Figure United States Anticoagulants Drug Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Anticoagulants Drug by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Anticoagulants Drug Market Size (Million USD) by Region (2012-2022)
Figure The West Anticoagulants Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Anticoagulants Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Anticoagulants Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Anticoagulants Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Anticoagulants Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Anticoagulants Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Anticoagulants Drug Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Anticoagulants Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Anticoagulants Drug Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Anticoagulants Drug Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Anticoagulants Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Anticoagulants Drug Sales Share by Players/Suppliers
Figure 2017 United States Anticoagulants Drug Sales Share by Players/Suppliers
Figure United States Anticoagulants Drug Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Anticoagulants Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Anticoagulants Drug Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Anticoagulants Drug Revenue Share by Players/Suppliers
Figure 2017 United States Anticoagulants Drug Revenue Share by Players/Suppliers
Table United States Market Anticoagulants Drug Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Anticoagulants Drug Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Anticoagulants Drug Market Share of Top 3 Players/Suppliers
Figure United States Anticoagulants Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Anticoagulants Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Anticoagulants Drug Product Category
Table United States Anticoagulants Drug Sales (K Pcs) by Region (2012-2017)
Table United States Anticoagulants Drug Sales Share by Region (2012-2017)
Figure United States Anticoagulants Drug Sales Share by Region (2012-2017)
Figure United States Anticoagulants Drug Sales Market Share by Region in 2016
Table United States Anticoagulants Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Anticoagulants Drug Revenue Share by Region (2012-2017)
Figure United States Anticoagulants Drug Revenue Market Share by Region (2012-2017)
Figure United States Anticoagulants Drug Revenue Market Share by Region in 2016
Table United States Anticoagulants Drug Price (USD/Pcs) by Region (2012-2017)
Table United States Anticoagulants Drug Sales (K Pcs) by Type (2012-2017)
Table United States Anticoagulants Drug Sales Share by Type (2012-2017)
Figure United States Anticoagulants Drug Sales Share by Type (2012-2017)
Figure United States Anticoagulants Drug Sales Market Share by Type in 2016
Table United States Anticoagulants Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Anticoagulants Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Anticoagulants Drug by Type (2012-2017)
Figure Revenue Market Share of Anticoagulants Drug by Type in 2016
Table United States Anticoagulants Drug Price (USD/Pcs) by Types (2012-2017)
Figure United States Anticoagulants Drug Sales Growth Rate by Type (2012-2017)
Table United States Anticoagulants Drug Sales (K Pcs) by Application (2012-2017)
Table United States Anticoagulants Drug Sales Market Share by Application (2012-2017)
Figure United States Anticoagulants Drug Sales Market Share by Application (2012-2017)
Figure United States Anticoagulants Drug Sales Market Share by Application in 2016
Table United States Anticoagulants Drug Sales Growth Rate by Application (2012-2017)
Figure United States Anticoagulants Drug Sales Growth Rate by Application (2012-2017)
Table C. H. Boehringer Sohn (Germany) Basic Information List
Table C. H. Boehringer Sohn (Germany) Anticoagulants Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure C. H. Boehringer Sohn (Germany) Anticoagulants Drug Sales Growth Rate (2012-2017)
Figure C. H. Boehringer Sohn (Germany) Anticoagulants Drug Sales Market Share in United States (2012-2017)
Figure C. H. Boehringer Sohn (Germany) Anticoagulants Drug Revenue Market Share in United States (2012-2017)
Table Bristol-Myers Squibb (US) Basic Information List
Table Bristol-Myers Squibb (US) Anticoagulants Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb (US) Anticoagulants Drug Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb (US) Anticoagulants Drug Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb (US) Anticoagulants Drug Revenue Market Share in United States (2012-2017)
Table Johnson & Johnson (US) Basic Information List
Table Johnson & Johnson (US) Anticoagulants Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Johnson & Johnson (US) Anticoagulants Drug Sales Growth Rate (2012-2017)
Figure Johnson & Johnson (US) Anticoagulants Drug Sales Market Share in United States (2012-2017)
Figure Johnson & Johnson (US) Anticoagulants Drug Revenue Market Share in United States (2012-2017)
Table Pfizer (US) Basic Information List
Table Pfizer (US) Anticoagulants Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer (US) Anticoagulants Drug Sales Growth Rate (2012-2017)
Figure Pfizer (US) Anticoagulants Drug Sales Market Share in United States (2012-2017)
Figure Pfizer (US) Anticoagulants Drug Revenue Market Share in United States (2012-2017)
Table Daiichi Sankyo (Japan) Basic Information List
Table Daiichi Sankyo (Japan) Anticoagulants Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Daiichi Sankyo (Japan) Anticoagulants Drug Sales Growth Rate (2012-2017)
Figure Daiichi Sankyo (Japan) Anticoagulants Drug Sales Market Share in United States (2012-2017)
Figure Daiichi Sankyo (Japan) Anticoagulants Drug Revenue Market Share in United States (2012-2017)
Table Portola Pharmaceuticals (US) Basic Information List
Table Portola Pharmaceuticals (US) Anticoagulants Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Portola Pharmaceuticals (US) Anticoagulants Drug Sales Growth Rate (2012-2017)
Figure Portola Pharmaceuticals (US) Anticoagulants Drug Sales Market Share in United States (2012-2017)
Figure Portola Pharmaceuticals (US) Anticoagulants Drug Revenue Market Share in United States (2012-2017)
Table Roche (Switzerland) Basic Information List
Table Roche (Switzerland) Anticoagulants Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Roche (Switzerland) Anticoagulants Drug Sales Growth Rate (2012-2017)
Figure Roche (Switzerland) Anticoagulants Drug Sales Market Share in United States (2012-2017)
Figure Roche (Switzerland) Anticoagulants Drug Revenue Market Share in United States (2012-2017)
Table Abbott (US) Basic Information List
Table Abbott (US) Anticoagulants Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Abbott (US) Anticoagulants Drug Sales Growth Rate (2012-2017)
Figure Abbott (US) Anticoagulants Drug Sales Market Share in United States (2012-2017)
Figure Abbott (US) Anticoagulants Drug Revenue Market Share in United States (2012-2017)
Table Siemens (Germany) Basic Information List
Table Siemens (Germany) Anticoagulants Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Siemens (Germany) Anticoagulants Drug Sales Growth Rate (2012-2017)
Figure Siemens (Germany) Anticoagulants Drug Sales Market Share in United States (2012-2017)
Figure Siemens (Germany) Anticoagulants Drug Revenue Market Share in United States (2012-2017)
Table Alere (US) Basic Information List
Table Alere (US) Anticoagulants Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Alere (US) Anticoagulants Drug Sales Growth Rate (2012-2017)
Figure Alere (US) Anticoagulants Drug Sales Market Share in United States (2012-2017)
Figure Alere (US) Anticoagulants Drug Revenue Market Share in United States (2012-2017)
Table CoaguSense (US) Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anticoagulants Drug
Figure Manufacturing Process Analysis of Anticoagulants Drug
Figure Anticoagulants Drug Industrial Chain Analysis
Table Raw Materials Sources of Anticoagulants Drug Major Players/Suppliers in 2016
Table Major Buyers of Anticoagulants Drug
Table Distributors/Traders List
Figure United States Anticoagulants Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Anticoagulants Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Anticoagulants Drug Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Anticoagulants Drug Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Anticoagulants Drug Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Anticoagulants Drug Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Anticoagulants Drug Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Anticoagulants Drug Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Anticoagulants Drug Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Anticoagulants Drug Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Anticoagulants Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Anticoagulants Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Anticoagulants Drug Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources